Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Gelfand

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|May 1, 1974
Ontogeny of B lymphocytes. II. Relative rates of appearance of lymphocytes bearing surface immunoglobulin and complement receptorsM C Gelfand, G J Elfenbein, M M Frank, et al.
The International Journal of Artificial Organs|November 1, 1979
Realities in evaluating the clinical uses of sorbent hemoperfusionJ F Winchester, M C Gelfand, J H Knepshield, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1973
Dialysis of poisons and drugs--annual reviewJ H Knepshield, G E Schreiner, D T Lowenthal, et al.
Artificial Organs|November 1, 1978
Present and future uses of hemoperfusion with sorbentsJ F Winchester, M C Gelfand, J H Knepshield, et al.
British Journal of Hospital Medicine|July 1, 1978
OverdoseJ F Winchester, J H Knepshield, M C Gelfand, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
Dialysis and hemoperfusion of poisons and drugs--updateJ F Winchester, M C Gelfand, J H Knepshield, et al.
Arthritis and Rheumatism|January 1, 1975
Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapyA D Steinberg, M C Gelfand, J A Hardin, et al.
Kidney International. Supplement|December 1, 1976
Treatment of hepatic coma with hemoperfusion through polyacrylamide hydrogel-coated charcoalM C Gelfand, J H Knepshield, S Cohan, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
Heparin associated hemodialysis hyperthyroidism (HHH): a physiologically significant phenomenonM C Gelfand, R Rodelas, J F McAnally, et al.
Clinical Immunology and Immunopathology|May 1, 1981
Binding of IgG-sensitized erythrocytes by mitral and aortic cardiac valves: a possible clue to the pathogenesis of immune valvular heart diseaseM C Gelfand, M Maclay, M L Shin, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|May 1, 1974
Ontogeny of B lymphocytes. II. Relative rates of appearance of lymphocytes bearing surface immunoglobulin and complement receptorsM C Gelfand, G J Elfenbein, M M Frank, et al.
The International Journal of Artificial Organs|November 1, 1979
Realities in evaluating the clinical uses of sorbent hemoperfusionJ F Winchester, M C Gelfand, J H Knepshield, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1973
Dialysis of poisons and drugs--annual reviewJ H Knepshield, G E Schreiner, D T Lowenthal, et al.
Artificial Organs|November 1, 1978
Present and future uses of hemoperfusion with sorbentsJ F Winchester, M C Gelfand, J H Knepshield, et al.
British Journal of Hospital Medicine|July 1, 1978
OverdoseJ F Winchester, J H Knepshield, M C Gelfand, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
Dialysis and hemoperfusion of poisons and drugs--updateJ F Winchester, M C Gelfand, J H Knepshield, et al.
Arthritis and Rheumatism|January 1, 1975
Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapyA D Steinberg, M C Gelfand, J A Hardin, et al.
Kidney International. Supplement|December 1, 1976
Treatment of hepatic coma with hemoperfusion through polyacrylamide hydrogel-coated charcoalM C Gelfand, J H Knepshield, S Cohan, et al.
Proceedings of the Clinical Dialysis and Transplant Forum|November 18, 1978
Heparin associated hemodialysis hyperthyroidism (HHH): a physiologically significant phenomenonM C Gelfand, R Rodelas, J F McAnally, et al.
Clinical Immunology and Immunopathology|May 1, 1981
Binding of IgG-sensitized erythrocytes by mitral and aortic cardiac valves: a possible clue to the pathogenesis of immune valvular heart diseaseM C Gelfand, M Maclay, M L Shin, et al.
Pageof 8